查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1618957

神经刺激设备的全球市场:产业分析，规模，占有率，成长，趋势，预测(2024年～2031年)

Neurostimulation Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 177 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计2024年全球神经刺激设备市场规模将达到67亿美元，2024年至2031年的预测期内复合年增长率为11.7%，预计到2031年将达到146亿美元。

神经刺激器对于治疗各种神经系统疾病和病症至关重要，包括慢性疼痛、癫痫、帕金森氏症和忧郁症。这些设备为神经系统的特定区域提供电刺激，调节神经活动，缓解症状，并改善患者的生活品质。神经刺激设备市场提供脊髓刺激器、深部脑部刺激器和迷走神经刺激器等多种设备，并且与医院、诊所和家庭护理环境相容。神经系统疾病的日益普及、设备技术的进步以及人们对神经刺激作为有效治疗工具的认识不断增强，推动了市场的成长。

全球神经刺激设备市场由几个关键因素推动，包括慢性疼痛以及癫痫和帕金森氏症等神经系统疾病盛行率的上升。对微创治疗方案的需求不断增长，以及设备小型化、充电电池和无线连接方面的进步，正在提高患者的舒适度并提高市场采用率。此外，老年人口的增加和医疗保健成本的上升正在推动对有效和长期神经治疗的需求，进一步推动市场成长。

神经刺激器市场的重大机会源自于技术进步、应用范围扩大和有利的人口趋势。设备设计的创新正在释放新的可能性，包括非侵入性刺激技术、人工智慧的整合以及改进的患者监测能力。神经刺激在肥胖管理、中风復健和偏头痛治疗等领域的新兴应用正在扩大市场范围。此外，研发投资的增加以及产业参与者之间的策略联盟正在为动态神经刺激市场的成长和创新创造道路。

本报告提供全球神经刺激设备市场相关调查，提供各产品类型，各用途，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围和定义
  • 市场动态
  • 宏观经济要素
  • COVID-19影响分析
  • 预测要素- 相关性及影响

第3章 附加价值的洞察

  • 产品招聘分析
  • 技术评估
  • 法规情形
  • 价值链分析
  • 主要的交易合併
  • 大环境分析
  • 波特的五力分析

第4章 价格趋势分析，2019年～2031年

第5章 全球神经刺激设备市场预测:实际成果(2019年～2023年)及预测(2024年～2031年)

  • 主要的焦点
  • 市场规模(10亿美元)分析与预测
  • 全球神经刺激设备市场预测:各产品类型
  • 全球神经刺激设备市场预测:各用途
  • 市场魅力分析:各用途
  • 全球神经刺激设备市场预测:各终端用户
  • 市场魅力分析:各终端用户

第6章 全球神经刺激设备市场预测:各地区

  • 主要的焦点
  • 过去的市场规模(10亿美元)和数量(台)的分析，各地区，2019年～2023年
  • 目前市场规模(10亿美元)和数量(台)的分析与预测，各地区，2023年～2031年
  • 市场魅力分析:各地区

第7章 北美的神经刺激设备市场预测:实际成果(2019年～2023年)及预测(2024年～2031年)

第8章 欧洲的神经刺激设备市场预测:实际成果(2019年～2023年)及预测(2024年～2031年)

第9章 东亚的神经刺激设备市场预测:实际成果(2019年～2023年)及预测(2024年～2031年)

第10章 南亚及大洋洲的神经刺激设备市场预测:实际成果(2019年～2023年)及预测(2024年～2031年)

第11章 南美的神经刺激设备市场预测:实际成果(2019年～2023年)及预测(2024年～2031年)

第12章 中东·非洲的神经刺激设备市场预测:实际成果(2019年～2023年)及预测(2024年～2031年)

第13章 竞争情形

  • 市场占有率分析，2023年
  • 市场结构
  • 企业简介(详细内容- 概要，财务，策略，最近的趋势)
    • Medtronic
    • Abbott
    • Boston Scientific Corporation
    • Cochlear Inc.
    • NDI Medical LLC
    • NeuroPace Inc.
    • MED-EL Medical Electronics
    • NeuroSigma Inc.

第14章 附录

简介目录
Product Code: PMRREP2824

Persistence Market Research has recently released a comprehensive report on the worldwide market for neurostimulation devices. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global neurostimulation devices market from 2024 to 2031.

Key Insights:

  • Neurostimulation Devices Market Size (2024E):US$ 6.7 Bn
  • Projected Market Value (2031F): US$ 14.6 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 11.7%

Neurostimulation Devices Market - Report Scope:

Neurostimulation devices are critical in treating various neurological disorders and conditions, including chronic pain, epilepsy, Parkinson's disease, and depression. These devices deliver electrical stimulation to specific areas of the nervous system to modulate neural activity, alleviate symptoms, and improve patient quality of life. The neurostimulation devices market caters to hospitals, clinics, and homecare settings, offering a variety of devices such as spinal cord stimulators, deep brain stimulators, and vagus nerve stimulators. Market growth is driven by the increasing prevalence of neurological disorders, advancements in device technology, and growing awareness of neurostimulation as an effective treatment modality.

Market Growth Drivers:

The global neurostimulation devices market is propelled by several key factors, including the rising incidence of chronic pain and neurological disorders, such as epilepsy and Parkinson's disease. Increasing demand for minimally invasive treatment options and advancements in device miniaturization, rechargeable batteries, and wireless connectivity are enhancing patient comfort and expanding market adoption. Additionally, the growing geriatric population and increasing healthcare expenditure are driving the demand for effective and long-term neurological treatments, further fueling market growth.

Market Restraints:

Despite promising growth prospects, the neurostimulation devices market faces challenges, including high device costs, regulatory hurdles, and potential side effects associated with neurostimulation therapy. Limited access to advanced healthcare infrastructure in developing regions and the lengthy approval process for new devices can restrict market growth. Furthermore, reimbursement constraints and patient skepticism regarding device implantation present additional barriers to widespread adoption.

Market Opportunities:

Significant opportunities in the neurostimulation devices market stem from technological advancements, expanding applications, and favorable demographic trends. Innovations in device design, such as non-invasive stimulation techniques, artificial intelligence integration, and improved patient monitoring capabilities, are unlocking new potential. Emerging applications of neurostimulation in conditions like obesity management, stroke rehabilitation, and migraine treatment broaden the market scope. Moreover, increasing investments in R&D and strategic collaborations among industry players create pathways for growth and innovation in the dynamic neurostimulation landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the neurostimulation devices market globally?
  • Which device types and applications are propelling neurostimulation adoption across various healthcare settings?
  • How are technological advancements shaping the competitive landscape of the neurostimulation devices market?
  • Who are the key players in the market, and what strategies are they employing to maintain competitiveness?
  • What are the emerging trends and future prospects in the global neurostimulation devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global neurostimulation devices market, including Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, and Nevro Corp., focus on innovation and strategic partnerships to strengthen their market positions. These companies are investing heavily in R&D to develop advanced neurostimulation solutions, such as closed-loop systems, wearable stimulators, and devices with enhanced connectivity. Collaborations with healthcare providers, research institutions, and regulatory agencies enable market access and facilitate the adoption of cutting-edge technologies. Emphasis on patient education, clinical research, and evidence-based practice further supports market expansion and improved patient outcomes.

Key Companies Profiled:

  • Medtronic PLC
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Nevro Corp.
  • LivaNova PLC
  • Cyberonics, Inc.
  • Stimwave LLC
  • NeuroPace, Inc.
  • Synapse Biomedical Inc.

Neurostimulation Devices Industry Segmentation

By Product Type

  • Spinal Cord Stimulators (SCS)
  • Deep Brain Stimulators (DBS)
  • Vagus Nerve Stimulators (VNS)
  • Sacral Nerve Stimulators
  • Transcranial Magnetic Stimulation (TMS) Devices
  • Transcutaneous Electrical Nerve Stimulation (TENS) Devices

By Application

  • Pain Management
  • Epilepsy
  • Depression
  • Parkinson's Disease

By End User

  • Hospitals
  • Clinics
  • Homecare Settings
  • Research Institutes

By Region

  • North America
  • Europe
  • Latin America
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Neurostimulation Devices Market Snapshot, 2024 and 2031
  • 1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Technology Assessment
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Price Trend Analysis, 2019 - 2031

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product Type
  • 4.4. Regional Prices and Product Type Preferences

5. Global Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024 - 2031
  • 5.3. Global Neurostimulation Devices Market Outlook: Product Type
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product Type, 2019 - 2023
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
      • 5.3.3.1. Spinal Cord Stimulators (SCS)
      • 5.3.3.2. Deep Brain Stimulators (DBS)
      • 5.3.3.3. Vagus Nerve Stimulators (VNS)
      • 5.3.3.4. Sacral Nerve Stimulators
      • 5.3.3.5. Transcranial Magnetic Stimulation (TMS) Devices
      • 5.3.3.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
    • 5.3.4. Market Attractiveness Analysis: Product Type
  • 5.4. Global Neurostimulation Devices Market Outlook: Application
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
    • 5.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
      • 5.4.3.1. Pain Management
      • 5.4.3.2. Epilepsy
      • 5.4.3.3. Depression
      • 5.4.3.4. Parkinson's Disease
      • 5.4.3.5. Others
  • 5.5. Market Attractiveness Analysis: Application
  • 5.6. Global Neurostimulation Devices Market Outlook: End User
    • 5.6.1. Introduction / Key Findings
    • 5.6.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
    • 5.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
      • 5.6.3.1. Hospitals
      • 5.6.3.2. Clinics
      • 5.6.3.3. Homecare Settings
      • 5.6.3.4. Research Institutes
  • 5.7. Market Attractiveness Analysis: End User

6. Global Neurostimulation Devices Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2023
  • 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2023 - 2031
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) and Analysis, By Market, 2019 - 2023
    • 7.2.1. By Country
    • 7.2.2. By Product Type
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 7.4.1. Spinal Cord Stimulators (SCS)
    • 7.4.2. Deep Brain Stimulators (DBS)
    • 7.4.3. Vagus Nerve Stimulators (VNS)
    • 7.4.4. Sacral Nerve Stimulators
    • 7.4.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 7.4.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 7.5.1. Pain Management
    • 7.5.2. Epilepsy
    • 7.5.3. Depression
    • 7.5.4. Parkinson's Disease
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 7.6.1. Hospitals
    • 7.6.2. Clinics
    • 7.6.3. Homecare Settings
    • 7.6.4. Research Institutes
  • 7.7. Market Attractiveness Analysis

8. Europe Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 8.3.1. By Country
    • 8.3.2. By Product Type
    • 8.3.3. By Application
    • 8.3.4. By End User
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. U.K.
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Russia
    • 8.4.7. Turkey
    • 8.4.8. Rest of Europe
  • 8.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 8.5.1. Spinal Cord Stimulators (SCS)
    • 8.5.2. Deep Brain Stimulators (DBS)
    • 8.5.3. Vagus Nerve Stimulators (VNS)
    • 8.5.4. Sacral Nerve Stimulators
    • 8.5.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 8.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 8.6.1. Pain Management
    • 8.6.2. Epilepsy
    • 8.6.3. Depression
    • 8.6.4. Parkinson's Disease
    • 8.6.5. Others
  • 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 8.7.1. Hospitals
    • 8.7.2. Clinics
    • 8.7.3. Homecare Settings
    • 8.7.4. Research Institutes
  • 8.8. Market Attractiveness Analysis

9. East Asia Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By Application
    • 9.3.4. By End User
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. South Korea
  • 9.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 9.5.1. Spinal Cord Stimulators (SCS)
    • 9.5.2. Deep Brain Stimulators (DBS)
    • 9.5.3. Vagus Nerve Stimulators (VNS)
    • 9.5.4. Sacral Nerve Stimulators
    • 9.5.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 9.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 9.6.1. Pain Management
    • 9.6.2. Epilepsy
    • 9.6.3. Depression
    • 9.6.4. Parkinson's Disease
    • 9.6.5. Others
  • 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 9.7.1. Hospitals
    • 9.7.2. Clinics
    • 9.7.3. Homecare Settings
    • 9.7.4. Research Institutes
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 10.3.1. India
    • 10.3.2. SEA
    • 10.3.3. ANZ
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 10.4.1. Spinal Cord Stimulators (SCS)
    • 10.4.2. Deep Brain Stimulators (DBS)
    • 10.4.3. Vagus Nerve Stimulators (VNS)
    • 10.4.4. Sacral Nerve Stimulators
    • 10.4.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 10.4.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 10.5.1. Pain Management
    • 10.5.2. Epilepsy
    • 10.5.3. Depression
    • 10.5.4. Parkinson's Disease
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 10.6.1. Hospitals
    • 10.6.2. Clinics
    • 10.6.3. Homecare Settings
    • 10.6.4. Research Institutes

11. Latin America Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 11.3.1. By Country
    • 11.3.2. By Product Type
    • 11.3.3. By Application
    • 11.3.4. By End User
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 11.5.1. Spinal Cord Stimulators (SCS)
    • 11.5.2. Deep Brain Stimulators (DBS)
    • 11.5.3. Vagus Nerve Stimulators (VNS)
    • 11.5.4. Sacral Nerve Stimulators
    • 11.5.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 11.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 11.6.1. Pain Management
    • 11.6.2. Epilepsy
    • 11.6.3. Depression
    • 11.6.4. Parkinson's Disease
    • 11.6.5. Others
  • 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 11.7.1. Hospitals
    • 11.7.2. Clinics
    • 11.7.3. Homecare Settings
    • 11.7.4. Research Institutes
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 12.3.1. By Country
    • 12.3.2. By Product Type
    • 12.3.3. By Application
    • 12.3.4. By End User
  • 12.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 12.4.1. GCC Countries
    • 12.4.2. Egypt
    • 12.4.3. South Africa
    • 12.4.4. Northern Africa
    • 12.4.5. Rest of Middle East & Africa
  • 12.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 12.5.1. Spinal Cord Stimulators (SCS)
    • 12.5.2. Deep Brain Stimulators (DBS)
    • 12.5.3. Vagus Nerve Stimulators (VNS)
    • 12.5.4. Sacral Nerve Stimulators
    • 12.5.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 12.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 12.6.1. Pain Management
    • 12.6.2. Epilepsy
    • 12.6.3. Depression
    • 12.6.4. Parkinson's Disease
    • 12.6.5. Others
  • 12.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 12.7.1. Hospitals
    • 12.7.2. Clinics
    • 12.7.3. Homecare Settings
    • 12.7.4. Research Institutes
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Medtronic
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product Types
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Abbott
    • 13.3.3. Boston Scientific Corporation
    • 13.3.4. Cochlear Inc.
    • 13.3.5. NDI Medical LLC
    • 13.3.6. NeuroPace Inc.
    • 13.3.7. MED-EL Medical Electronics
    • 13.3.8. NeuroSigma Inc.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations